HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N-(deoxyguanosin-8-yl)-4-aminobiphenyl

Also Known As:

dG-8-ABP; dGuo-8-ABP

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Hatcher, James F: 2 articles (02/2002 - 01/2002)
2.	Swaminathan, Santhanam: 2 articles (02/2002 - 01/2002)
3.	Burger, M S: 1 article (01/2001)
4.	Reznikoff, C A: 1 article (01/2001)
5.	Swaminathan, S: 1 article (01/2001)
6.	Torino, J L: 1 article (01/2001)

Related Diseases

1.	Urinary Bladder Neoplasms (Bladder Cancer) 05/12/1997 - "From our studies of chronic ABP exposure in male mice, we have obtained the daily dose of ABP and the steady-state level of N-(deoxyguanosin-8-yl)-4-aminobiphenyl (dG-C8-ABP) adduct associated with a 50% mouse bladder tumor incidence. "
2.	Carcinogenesis 02/20/2002 - "TLC of the postlabeled products on the first dimension revealed several products, the majority of which stayed close to the origin and were earlier identified as the 3',5' -bisphospho derivatives of N-(deoxyguanosin-8-yl)-4-aminobiphenyl and N-(deoxyadenosin-8-yl)-4-aminobiphenyl (Carcinogenesis 13 (1993) 955; Carcinogenesis 16 (1995) 295). " 01/01/2002 - "Two adducts detected by (32)P-postlabeling were previously identified as the 3',5'-bisphospho derivatives of N-(deoxyguanosin-8-yl)-4-aminobiphenyl (dG-C8-ABP) and N-(deoxyadenosin-8-yl)-4-aminobiphenyl (dA-C8-ABP) (Frederickson S et al. [1992] Carcinogenesis 13: 955-961; Hatcher and Swaminathan [1995b] Carcinogenesis 16: 295-301). "
3.	Transitional Cell Carcinoma 01/01/2001 - "Role of TP53 in repair of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human transitional cell carcinoma of the urinary bladder."

Related Drugs and Biologics

1.	N-(deoxyadenosin-8-yl)-4-aminobiphenyl